Baxter International Inc. and other drug companies sold blood-clotting medicine
for hemophiliacs that carried a high risk of transmitting AIDS to markets in
Europe more than a year after switching to newer, safer products in the United
States, according to a lawsuit filed Friday.
Chicago
Sun-Times (http://www.suntimes.com/output/business/cst-fin-drug25.html)